AzTrials
AzTrials

HivNCT04275310

Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women

A study testing Microeconomic Intervention in people with Hiv and Transgenderism, run by Virginia Commonwealth University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this research study is to learn more about the economic situations, discrimination experiences, and risk behaviors of transgender women. The ultimate purpose of the study is to test an intervention to improve financial conditions and reduce HIV risk behaviors in transgender women. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Hiv, Transgenderism
What is being tested?
Microeconomic Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
1 siteUnited States
Study dates
20 Jul 2022to 17 Nov 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Transgender woman
  • 18-45 years of age
  • At least one of the following economic vulnerability factors:
  • unemployment or underemployment [less than 20 hours/week], low income [less than the Medicaid poverty threshold], housing insecurity in the past year or food insecurity in the past year
  • Behavioral vulnerability to HIV transmission (reported at least one episode of unprotected sex in prior 6 months or at least one other behavioral HIV transmission risk factor in the past 6 months: [transactional sex, multiple sexual partners, 1-time sexual partner, sex under the influence of drugs or alcohol, sex with partner of unknown HIV status).

Who cannot join

  • obvious signs of intoxication or cognitive impairment
  • cannot speak English.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Virginia Commonwealth University

    Richmond, Virginia, 23298

Other trials in United States

About this study

The purpose of this research study is to learn more about the economic situations, discrimination experiences, and risk behaviors of transgender women. The ultimate purpose of the study is to test an intervention to improve financial conditions and reduce HIV risk behaviors in transgender women.

Read the detailed description

The study includes a microeconomic intervention which will provide education on a variety of economic and behavioral topics. Participants will complete questionnaires on multiple occasions during the study.

Conditions
Hiv, Transgenderism
Being tested
Microeconomic Intervention
Medical subject headings
Acquired Immunodeficiency Syndrome, Transsexualism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Microeconomic InterventionBehavioural

    The intervention will consist of six sessions on six different days. Sessions will be held at VCU or at one of VCU's community partners. Each session will last for around 2 ½ hours (around 15 hours total). There will be breaks and food will be provided. During the sessions the facilitators will provide education on a variety of topics, including economic services that are available to people living in Richmond, job skills (such as creating a resume and dealing with discrimination at work), personal finance education, gender transition ideas, and HIV prevention. The sessions will occur in a group of about 4-10 transgender women.

Study groups in NCT04275310
Study groupRoleWhat they receive
Microeconomic interventionExperimentalNot described
Receives: Behavioral: Microeconomic Intervention
Waitlisted controlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Employment Status

    Number of participants whose status with respect to employment improves after the intervention.

    Measured: Baseline to up to 9 months

  2. Change in Income

    Number of participants whose income increases after the intervention.

    Measured: Baseline to up to 9 months

  3. Change in Housing Stability

    Number of participants whose access to stable permanent housing improves after the intervention.

    Measured: Baseline to up to 9 months

  4. Change in Savings

    Number of participants whose savings increase after the intervention.

    Measured: Baseline to up to 9 months

  5. Change in Self Reported HIV Risk Behavior

    Number of participants whose self-reports of behaviors known to increase risk for HIV goes down after the intervention.

    Measured: Baseline to up to 9 months

  6. Change in Compliance With Recommended Biomedical Prevention or Treatment

    Number of participants who demonstrate higher compliance with recommended biomedical prevention or treatment behaviors after the intervention.

    Measured: Baseline to up to 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2020
  2. Study start20 Jul 2022
  3. Primary completion17 Nov 2022
  4. Study completion17 Nov 2022

Why it stopped: Loss of funding

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04275310
Sponsor's protocol ID
HM20011245
Other IDs
R34MH115775
Status last verified
Aug 2023
First submitted
12 Feb 2020
Last updated
4 Aug 2023
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Microeconomic Intervention in people with Hiv and Transgenderism, run by Virginia Commonwealth University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 4 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 4 Aug 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Employment Status (time frame: Baseline to up to 9 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in